Hong-Yan Gu

2.4k total citations
40 papers, 2.1k citations indexed

About

Hong-Yan Gu is a scholar working on Pharmacology, Molecular Biology and Plant Science. According to data from OpenAlex, Hong-Yan Gu has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 19 papers in Molecular Biology and 15 papers in Plant Science. Recurrent topics in Hong-Yan Gu's work include Natural Compound Pharmacology Studies (14 papers), Synthesis of Organic Compounds (10 papers) and Flavonoids in Medical Research (8 papers). Hong-Yan Gu is often cited by papers focused on Natural Compound Pharmacology Studies (14 papers), Synthesis of Organic Compounds (10 papers) and Flavonoids in Medical Research (8 papers). Hong-Yan Gu collaborates with scholars based in China, United States and Czechia. Hong-Yan Gu's co-authors include Qinglong Guo, Qidong You, Yong Yang, Qi Qi, Li Zhao, Na Lu, Xiaotang Wang, Zhao‐Qiu Wu, Rong Mu and Jia Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Tetrahedron and Biochemical Pharmacology.

In The Last Decade

Hong-Yan Gu

39 papers receiving 2.0k citations

Peers

Countries citing papers authored by Hong-Yan Gu

Since Specialization

Citations

This map shows the geographic impact of Hong-Yan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Yan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Yan Gu more than expected).

Fields of papers citing papers by Hong-Yan Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong-Yan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Yan Gu. The network helps show where Hong-Yan Gu may publish in the future.

Co-authorship network of co-authors of Hong-Yan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Yan Gu. A scholar is included among the top collaborators of Hong-Yan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Yan Gu. Hong-Yan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dipenipenoids C and D, new dimeric indole-diterpenoids from the marine-derived fungus Penicillium sp. CF-06 2025 ·Tetrahedron ·(unknown), Wenbin Gao, Hong-Yan Gu, (unknown), Fei Cao	0
2	A combination of Beers and STOPP criteria better detects potentially inappropriate medications use among older hospitalized patients with chronic diseases and polypharmacy: a multicenter cross-sectional study 2023 ·BMC Geriatrics ·(unknown), Ke Wang, Kun Yang, Dechun Jiang, Xianghua Fang, Su Su, Yang Lin, Shicai Chen, Hong-Yan Gu, Pengmei Li, Suying Yan	10
3	The impact of pharmacist practice of medication therapy management in ambulatory care: an experience from a comprehensive Chinese hospital 2023 ·BMC Health Services Research ·(unknown), (unknown), Yingjie Ma, Yuanyuan Wei, Xiaowei Ma, Lu Yang, (unknown), (unknown), Zhe Wang, Xiaomei Tao, (unknown), Rui Jin, Hong-Yan Gu	9
4	Comparison of the prevalence and nature of potentially inappropriate medication use in geriatric outpatients between tertiary and community healthcare settings: a multicenter cross-sectional study 2022 ·International Journal of Clinical Pharmacy ·Yan Zeng, (unknown), Qingyang Liu, Su Su, Yang Lin, Hong-Yan Gu, Shicai Chen, Pengmei Li, Tong Xu, (unknown), (unknown), Qian Huang, Yujie Fan, Fengzhi Wang, Suying Yan	9
5	Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153 2011 ·Neoplasma ·Ning Wu, Chang Gu, Hong-Yan Gu, Haoyue Hu, Yuxiang Han, (unknown)	100
6	Hybrid cells differentiate to hepatic lineage cells and repair oxidative damage 2010 ·Cellular & Molecular Biology Letters ·Dan Xu, (unknown), Hong-Yan Gu, Jia Wang, Qinglong Guo, Yanli Zhang, Ziyu Wang	3
7	Gambogic acid‐induced degradation of mutant p53 is mediated by proteasome and related to CHIP 2010 ·Journal of Cellular Biochemistry ·Jia Wang, Qing Zhao, Qi Qi, Hong-Yan Gu, Jingjing Rong, Rong Mu, Meijuan Zou, Lei Tao, Qidong You, Qinglong Guo	56
8	Studies on the toxicity of gambogic acid in rats 2008 ·Journal of Ethnopharmacology ·Qi Qi, Qidong You, Hong-Yan Gu, Li Zhao, Wei Liu, Na Lu, Qinglong Guo	68
9	Oroxylin A induces G<SUB>2</SUB>/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells 2008 ·Journal of Pharmacy and Pharmacology ·Yong Yang, Yang Hu, Hong-Yan Gu, Na Lu, Wei Liu, Qi Qi, Li Zhao, Xiaotang Wang, Qidong You, Qinglong Guo	39
10	Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis 2008 ·Journal of Molecular Medicine ·Qi Qi, Hong-Yan Gu, Yong Yang, Na Lu, Jie Zhao, Wei Liu, Hua Ling, Qidong You, Xiaotang Wang, Qinglong Guo	52
11	Inhibition of α4 integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with Gambogic acid 2008 ·European Journal of Pharmacology ·Jie Zhao, Qi Qi, Yong Yang, Hong-Yan Gu, Na Lu, Wei Liu, Wei Wang, Lei Qiang, (unknown), Qidong You, Qinglong Guo	41
12	Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice 2008 ·International Immunopharmacology ·Hong-Yan Gu, Qidong You, Wei Liu, Yong Yang, Li Zhao, Qi Qi, Jie Zhao, Jia Wang, Na Lu, Hua Ling, Qinglong Guo, Xuemin Wang	29
13	Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes 2007 ·Cancer Letters ·Yong Yang, Lan‐Yan Yang, Qidong You, Fei-Fei Nie, Hong-Yan Gu, Li Zhao, Xuemin Wang, Qinglong Guo	127
14	Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study 2007 ·Biochemical Pharmacology ·Lei Qiang, Yong Yang, Qidong You, Yanjun Ma, Lan‐Yan Yang, Fei-Fei Nie, Hong-Yan Gu, Li Zhao, Na Lu, Qi Qi, Wei Liu, Xuemin Wang, Qinglong Guo	72
15	Anti-hepatitis B virus activity of wogonin in vitro and in vivo 2007 ·Antiviral Research ·Qinglong Guo, Li Zhao, Qidong You, Yong Yang, Hong-Yan Gu, (unknown), Na Lu, Jian Xin	149
16	Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1 2007 ·Cancer Letters ·Na Lu, Yong Yang, Qidong You, Yun Ling, Ying Gao, Hong-Yan Gu, Li Zhao, Xuemin Wang, Qinglong Guo	88
17	Toxicological Studies of Gambogic Acid and its Potential Targets in Experimental Animals 2006 ·Basic & Clinical Pharmacology & Toxicology ·Qinglong Guo, Qi Qi, Qidong You, Hong-Yan Gu, Li Zhao, Zhao‐Qiu Wu	50
18	Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity 2006 ·Biochemical and Biophysical Research Communications ·Yang Hu, Yong Yang, Qidong You, Wei Liu, Hong-Yan Gu, Li Zhao, Kun Zhang, Wei Wang, Xiaotang Wang, Qinglong Guo	77
19	The Anticancer Activities of Wogonin in Murine Sarcoma S180 both in Vitro and in Vivo 2006 ·Biological and Pharmaceutical Bulletin ·Wei Wang, Qinglong Guo, Qidong You, Kun Zhang, Yong Yang, Jun Yu, Wei Liu, Li Zhao, Hong-Yan Gu, Yang Hu, Zi Tan, Xiaotang Wang	65
20	Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells 2005 ·Life Sciences ·Qinglong Guo, Sensen Lin, Qidong You, Hong-Yan Gu, Jun Yu, Li Zhao, Qi Qi, Fei Liang, Zi Tan, Xiaotang Wang	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact